Clinical Trial Update: Role of Vitamin D in Reducing the Relapse Rate in Patients With Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating whether Vitamin D supplementation can reduce relapse rates in patients with multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Vitamin D (Cholecalciferol)

Snippet

Sponsor: AlJohara M AlQuaiz, M.D. | Conditions: Multiple Sclerosis | Phase 2 | Status: UNKNOWN